- Home
- THTX vs MGRM Comparison
THTX vs MGRM Comparison
Compare THTX & MGRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- MGRM
- Stock Information
- Founded
- THTX 1993
- MGRM 2016
- Country
- THTX Canada
- MGRM United States
- Employees
- THTX N/A
- MGRM N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- MGRM Medical/Dental Instruments
- Sector
- THTX Health Care
- MGRM Health Care
- Exchange
- THTX Nasdaq
- MGRM Nasdaq
- Market Cap
- THTX 93.3M
- MGRM 89.6M
- IPO Year
- THTX N/A
- MGRM N/A
- Fundamental
- Price
- THTX $1.72
- MGRM $2.57
- Analyst Decision
- THTX Hold
- MGRM Strong Buy
- Analyst Count
- THTX 1
- MGRM 1
- Target Price
- THTX N/A
- MGRM $4.00
- AVG Volume (30 Days)
- THTX 178.5K
- MGRM 63.8K
- Earning Date
- THTX 02-19-2025
- MGRM 03-14-2025
- Dividend Yield
- THTX N/A
- MGRM N/A
- EPS Growth
- THTX N/A
- MGRM N/A
- EPS
- THTX N/A
- MGRM N/A
- Revenue
- THTX $84,316,000.00
- MGRM $364,999.00
- Revenue This Year
- THTX $5.78
- MGRM N/A
- Revenue Next Year
- THTX $2.47
- MGRM N/A
- P/E Ratio
- THTX N/A
- MGRM N/A
- Revenue Growth
- THTX 5.75
- MGRM N/A
- 52 Week Low
- THTX $1.08
- MGRM $1.53
- 52 Week High
- THTX $2.18
- MGRM $4.90
- Technical
- Relative Strength Index (RSI)
- THTX 50.28
- MGRM 54.65
- Support Level
- THTX $1.69
- MGRM $2.35
- Resistance Level
- THTX $1.83
- MGRM $2.80
- Average True Range (ATR)
- THTX 0.13
- MGRM 0.20
- MACD
- THTX -0.04
- MGRM -0.01
- Stochastic Oscillator
- THTX 19.30
- MGRM 54.00
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.